The COVID-19 widespread has the bioprocessing division fighting to keep staff safe while maintaining the supply chain for immunization advancement. Researchers and specialists around the world are racing to decrease the spread of the disease.
Both the United States and the European Union have already taken measures to restrict travel and are prompting individuals to constrain contact with others. Endeavors in creating a SAR-CoV-2 antibody have also been quickened, affecting the bioprocessing innovation and services industry.
Satarious’s spokesperson, Timo Lindemann said that they have been extending support to various customers developing a vaccine against COVID-19 and possibly during its production as well. However, he added that forecasting the next steps amid the pandemic poses a challenge to do so, especially due to the limited supply chain.
They have taken measures to ensure that the safety and well-being of its employees are of top priority by suspending business trips and implementing working from home.
GE Healthcare’s spokesperson also said that they have also taken measures to protect the welfare of its employees as they work closely with local governments against COVID-19.
Similarly, Thermo Fisher Scientific has also been keeping a close eye on the situation as they also implement measures to ensure the safety of its employees through travel bans and moved meetings with customers virtually.